• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Gulden introduces Aurosling for surgical correction of ptosis

Article

New device for surgical correction of ptosis.

Elkins Park, PA-Gulden Ophthalmics introduces Aurosling, the frontalis suspension sling used in the surgical procedure for the correction of ptosis. The frontalis sling procedure, the most common surgery for ptosis, uses the frontalis muscle of the forehead to help lift the eyelid by placing a sling of material between the forehead and the eyelid.

Aurosling is a sterile implantable flexible silicone rod with a silicone sleeve attached to two malleable sharp straight needles. Silicone, unlike other materials, is not associated with frequent recurrence of ptosis and is often used as a permanent solution. The material can be adjusted, both intraoperatively and post-operatively, if the eyelid height needs to be altered over time.

The 40 cm, flexible silicone rod helps in good lid closure and provides excellent bio-compatibility. The 7 mm-long sleeve helps in easy adjustments and facilitates easy implantation. Needle length is 6.3cm, diameter is 920 micron.

Related Videos
World Optometry Day 2024
Nicholas Gilberg, OD, gives a tutorial on EssilorLuxottica's Leonardo team practice management programs
Chris and Jamie Shyer, Zyloware Eyewear co-CEOs, after their NOW Optical Lifetime Achievement award win at Vision Expo East
Jessica Steen, OD, FAAO, discusses systemic medication and ocular adverse effects at Vision Expo East 2024
At Vision Expo East 2024, Srinivas Kondapalli, MD, demonstrates how to use Rinsada to address ocular surface disease.
Brujic at Rinsada Booth at Vision Expo East 2024
© 2024 MJH Life Sciences

All rights reserved.